Drugs / Local OPV
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00829010 Background | Feb 2009 → Jun 2011 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Local OPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00829010 ↗ |
| Known as | oral poliovirus vaccine | “oral poliovirus vaccine” NCT00829010 ↗ |
| Modality | Vaccine | “oral poliovirus vaccine” NCT00829010 ↗ |
| Route | Oral | “Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine” NCT00829010 ↗ |